Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL‐60 leukemic cell line
- 15 March 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 56 (6) , 906-909
- https://doi.org/10.1002/ijc.2910560625
Abstract
A butyric acid pro‐drug, pivaloyioxymethyl butyrate, AN‐9, developed in our laboratory, was previously shown to act as a differentiation‐inducing and an anti‐cancer agent. In this study we have shown that both AN‐9 and butyric acid caused a transient hyperacetylation of histones, which returned to basal levels after 6 and 12 hr, respectively. This activity precedes the induction of differentiation elicited by both agents. AN‐9 induced acetylation of histones at a concentration one order of magnitude lower than butyric acid. Pre‐treatment of the cells with esterase(s) inhibitors diminished the ability of AN‐9 to inhibit proliferation and induce differentiation. The above suggests that the intracellular release of butyric acid fragment, from the pro‐drug, is catalyzed by cellular esterase(s).Keywords
This publication has 23 references indexed in Scilit:
- Retinoic acid inhibits sodium butyrate-induced monocytic differentiation of HL60 cells while synergistically inducing granulocytoid differentiationEuropean Journal of Haematology, 2009
- Rapid alteration of c‐myc and c‐jun expression in leukemic cells induced to differentiate by a butyric acid prodrugFEBS Letters, 1993
- Derivatives of butyric acid as potential anti‐neoplastic agentsInternational Journal of Cancer, 1991
- Patterns of histone acetylationEuropean Journal of Biochemistry, 1990
- Comparison of the Effects of Forskolin and Dibutyryl Cyclic AMP in Neuroblastoma Cells: Evidence that Some of the Actions of Dibutyryl Cyclic AMP Are Mediated by ButyrateJournal of Neurochemistry, 1988
- Towards an understanding of the biological function of histone acetylationFEBS Letters, 1988
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Esters of N,N-disubstituted 2-hydroxyacetamides as a novel highly biolabile prodrug type for carboxylic acid agentsJournal of Medicinal Chemistry, 1987
- Butyric acid: A small fatty acid with diverse biological functionsLife Sciences, 1980
- Sodium butyrate inhibits histone deacetylation in cultured cellsCell, 1978